# Problem Specification

> Grounding: abstract-only. Source content is limited to `metadata.json` and `metadata.md`.

## Observations

### O01: AD and other dementias are framed as a growing global public-health burden
- **Statement**: Alzheimer's disease and other dementias are described as "major public health concerns with an increasing global impact."
- **Evidence**: metadata.md, Abstract.
- **Implication**: Burden estimation and trend analysis are public-health priorities.

### O02: Burden varies across demographic and geographic strata
- **Statement**: The abstract states that burden varies by region, age, and gender.
- **Evidence**: metadata.md, Abstract.
- **Implication**: Global aggregates are insufficient; stratified regional, age, and gender analysis is needed.

### O03: COVID-19 may have exacerbated disparities
- **Statement**: The abstract states that the COVID-19 pandemic further exacerbated disparities and potentially influenced prevalence, mortality, and disability burden.
- **Evidence**: metadata.md, Abstract.
- **Implication**: Pandemic-period analysis requires comparing observed outcomes to expected counterfactual outcomes.

### O04: 2021 mortality and prevalence were large in adults aged 60 years or older
- **Statement**: In 2021, global mortality from AD and other dementias among individuals aged 60 and older reached approximately 1,922,970.75 cases (95% CI: 480,348.08 to 5,104,315.95), and prevalence was 52,560,253.51 cases (95% CI: 41,399,948.84 to 65,633,448.71).
- **Evidence**: metadata.md, Abstract.
- **Implication**: The 2021 burden is substantial even before considering future demographic growth.

### O05: The abstract reports declining incidence rates alongside rising total burden
- **Statement**: The abstract states that incidence rates declined from 1990 to 2021 while the overall burden remains substantial and is expected to rise significantly by 2050.
- **Evidence**: metadata.md, Abstract.
- **Implication**: Rate trends and absolute case burdens can move in different directions under demographic change.

## Gaps

### G01: Regional and subgroup values are not available from provided input
- **Statement**: The abstract names regional, age, gender, SDI, and inequality analyses but does not provide detailed estimates for those strata.
- **Caused by**: O02, O03.
- **Existing attempts**: GBD 2021 analysis, health inequality analysis, and decomposition analysis are named.
- **Why they fail**: Not available from provided input.

### G02: Full model specifications are unavailable
- **Statement**: EAPC, BAPC, excess mortality comparisons, and decomposition analysis are named, but model equations, priors, covariates, and implementation details are not provided.
- **Caused by**: Abstract-only input.
- **Existing attempts**: Joinpoint Regression model, StataMP 18, and R 4.4.1 are named.
- **Why they fail**: Not available from provided input.

### G03: Tables, figures, and supplementary evidence cannot be enumerated
- **Statement**: No full text, PDF, numbered table list, or numbered figure list was provided.
- **Caused by**: Abstract-only input.
- **Existing attempts**: Not available from provided input.
- **Why they fail**: Not available from provided input.

## Key Insight

- **Insight**: A unified GBD 2021 analysis can combine historical burden trends, pandemic excess-mortality comparison, decomposition of demographic/epidemiological drivers, inequality analysis, and 2050 projection to characterize dementia burden among adults aged 60 years or older.
- **Derived from**: O01-O05.
- **Enables**: Claims about current burden, prominent risk factors, projected growth, health inequality, and uneven pandemic effects.

## Assumptions

- A1: The abstract's reported values and methods accurately summarize the article.
- A2: GBD 2021 data are the source for estimates from 1990 to 2021.
- A3: Detailed regional, model, figure, and table content not present in metadata is unavailable and must not be reconstructed.
